StockData
Freenome, Inc. logo

Freenome, Inc. (FRNM) stock

FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.73−0.09 (-0.92%)

Close on Nov 18, 2026Market cap $1.08BP/E –Yield –

Freenome operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Freenome's operating income for the twelve months ending Sep 30, 2026 was $250.71M. For fiscal 2025 it was -$2.98M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.98M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$69.97M–
Q2 FY2026Jun 30, 2026-$941.33K–
Q1 FY2026Mar 31, 2026-$858.83K–
Q4 FY2025Dec 31, 2025$182.54M–
Q3 FY2025Sep 30, 2025-$65.26M–
Q2 FY2025Jun 30, 2025-$193.20K–
Q1 FY2025Mar 31, 2025-$255.96K–
Q3 FY2024Sep 30, 2024-$196.13K–
Q2 FY2024Jun 30, 2024-$121.95K–

More Freenome figures

See a number that looks wrong?